Tilray Brands (TLRY) Gross Profit Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) Gross Profit Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.43% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -8.36% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.56% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -3.83% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 9.27% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 38.19% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 11.92% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | 33.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 33.84% |
| Feb 28, 2026 | 5.66% |
| Nov 30, 2025 | -6.08% |
| Aug 31, 2025 | -3.75% |
| May 31, 2025 | -17.87% |
| Feb 28, 2025 | 5.29% |
| Nov 30, 2024 | 29.13% |
| Aug 31, 2024 | 35.09% |
| May 31, 2024 | 22.61% |
| Feb 29, 2024 | 522.22% |
| Nov 30, 2023 | 10.56% |
| Aug 31, 2023 | -9.09% |
| May 31, 2023 | 1,097.52% |
| Feb 28, 2023 | -129.37% |
| Nov 30, 2022 | 30.87% |
| Aug 31, 2022 | -4.59% |
| May 31, 2022 | -129.93% |
| Feb 28, 2022 | 30.78% |
| Nov 30, 2021 | -7.13% |
| Aug 31, 2021 | 45.81% |